|
|
||||||||



* Dermatology Branch, Center for Cancer Research, National Cancer Institute, and
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
It is now clear from numerous in vitro studies that there are at least two pathways by which HIV interacts with DC: 1) CD4- and CCR5-mediated infection by virus and 2) cell surface capture of virus by DC-specific ICAM-3 grabbing nonintegrin and other C-type lectins (5, 6, 7, 8, 9, 10, 11). Using a tissue explant model, however, we found no evidence that C-type lectins expressed by LC within epithelium are involved in transmission of virus from LC to CD4+ T cells (11). Unlike monocyte-derived DC that can capture HIV via DC-specific ICAM-3 grabbing nonintegrin and transmit virus in trans to T cells (6), LC-mediated transmission of virus to T cells requires LC infection in a CD4- and CCR5-dependent manner (11). Our work with LC, as well as the macaque findings by Hu et al. (1), suggests that infection of LC, rather than capture of virus by LC, is an early biologic event that occurs during sexual transmission of HIV.
Single mature LC and other types of mature DC possess the characteristic ability to cluster with numerous T cells during immune activation. In addition, the DC-T cell microenvironment has been described as an "explosive" site for HIV replication, with many studies now showing transmission of virus to T cells by LC and other types of DC (5, 8, 9, 10, 11, 12, 13). This phenomenon is likely to be important in understanding several biologic aspects of HIV transmission. For instance, efficient LC-mediated transmission of HIV to T cells could sufficiently explain how virus could move from mucosal tissues and gain rapid access to draining lymph nodes (the normal sites of LC emigration following Ag exposure). This phenomenon also explains how minute amounts of infecting virus or how relatively few infected LC could lead to productive infection of large numbers of CD4+ T cells.
Previously, using a different model system, we showed that HIV preferentially infected HIV-specific CD4+ T cells (14). The precise nature of the type of T cells that become infected by HIV-infected LC, however, is unknown. In this study, we examined this issue by infecting human LC with HIV ex vivo and subsequently coculturing these cells with autologous memory and naive CD4+ T cells. Using multicolor flow cytometric analyses of LC-CD4+ T cell cocultures, we document that HIV-infected LC preferentially transmitted virus to proliferating, CD4+ memory T cells located within LC-T cell clusters. These results suggest that disrupting cluster formation between LC and CD4+ T cells may be a novel strategy to interfere with sexual transmission of HIV.
| Materials and Methods |
|---|
|
|
|---|
The Institutional Review Board of the National Cancer Institute approved all aspects of this study, and informed consent was obtained from all healthy individuals volunteering for the suction blister procedure and venipuncture.
Reagents
All of the murine mAbs were purchased from BD PharMingen (San Diego, CA), except for FITC-conjugated rat anti-p24 mAb (Beckman Coulter, Fullerton, CA). CFSE was purchased from Molecular Probes (Eugene, OR), and staphylococcal enterotoxin B (SEB) and brefeldin A were purchased from Sigma-Aldrich (St. Louis, MO). Purified, pelleted, and titered HIV-1Ba-L (stock at 2.47 x 1010 virus particles/ml) was purchased from Advanced Biotechnologies (Columbia, MD).
HIV infection of LC ex vivo
Epithelial tissue explants were prepared from suction blister roofs of healthy volunteers, and LC within these explants were infected as previously described (9, 11). Briefly, 50 µl droplets containing HIV-1Ba-L at 1/10 dilution in RPMI 1640 were placed on the inside surface of sterile plastic culture dish covers and explants were draped over droplets and incubated together at 37°C for 2 h. Explants were washed three times with sterile PBS, and then floated in 6-well plates containing 4 ml of complete medium.
Assessment of HIV infection in LC
LC that had emigrated from explants were collected 3 day following HIV exposure, preincubated in staining buffer for 10 min at room temperature to block nonspecific staining, and then incubated with 10 µg/ml PE-conjugated mouse anti-human HLA-DR mAb for 30 min at 4°C. Cells were then incubated with Dead Red (Molecular Probes) for 20 min at room temperature to label dead cells and fixed and permeabilized with Cytofix/Cytoperm reagents (BD PharMingen) for 20 min at 4°C. Cells were then incubated with 10 µg/ml FITC-conjugated rat anti-p24 mAb diluted in Perm/Wash for 30 min at 4°C and examined by flow cytometry using a FACScan (BD Biosciences, Mountain View, CA) equipped with Lysis II software (BD Biosciences). Dead cells, i.e., Dead-Red positive cells, were excluded from all analyses.
Isolation of autologous CD4+ T cells
Because we wanted to use T cells for functional assays following purification, negative selection of T cells was chosen for these experiments to avoid the possibility of unwanted cellular activation that can occur with positive selection. PBMC were collected from venous blood and separated by Ficoll-Hypaque density gradient centrifugation (Pharmacia, Uppsala, Sweden). CD4+ T cells were purified by depletion of CD8+, CD14+, CD15+, CD19+, and CD56+ cells using magnetic microbeads and sequential separation by AutoMacs (Miltenyi Biotec, Auburn, CA). Naive and memory CD4+ T cells were negatively selected further by depletion of CD57+ and CD45RO+ or CD45RA+ cells, respectively, using FITC-conjugated Abs and anti-FITC microbeads. The phenotype of the naive CD4+ T cells isolated with this sorting procedure was CD45RA+/CD27+/CD11adull/CD28dull/CD62L+/CCR7+, whereas the phenotype of the memory CD4+ T cells was CD45RO+/CD27+/-/CD11abright/CD28bright/CD62L+/-/CCR7+/-. Following purification, naive and memory CD4+ T cells were highly enriched (>96%) as determined by flow cytometry. We cannot exclude the possibility that our T cell populations contained trace amounts of blood myeloid and/or plasmacytoid DC.
CFSE labeling of CD4+ T cells
Naive and memory autologous CD4+ T cells were suspended in PBS at a concentration of 1 x 106/ml. Cells were incubated in 0.25 µM CFSE at 37°C for 7 min. CFSE-labeled cells were washed three times with PBS supplemented with 10% FCS. Cell viability was determined by trypan blue exclusion before coculture with LC.
Coculture of HIV-infected LC with autologous CD4+ T cells
HIV exposed or unexposed LC were thoroughly washed to minimize transfer of residual non-cell-associated virus and then cocultured with either autologous CD4+ naive or memory T cells in round-bottom 96-well plates at an LC to T cell ratio of 1:20 in RPMI 1640 medium supplemented with 20% human AB-serum and antibiotics. SEB was added to some cultures at 10 µg/ml. The cells were cultured for 72 or 96 h.
Multicolor flow cytometric analyses
Cells were harvested and surfaced stained with anti-CD1a allophycocyanin and CD3 Cascade blue (Molecular Probes) for 15 min in 4°C. Cells were then fixed and permeabilized for intracellular staining of HIV-1 p24 using anti-p24 PE as previously described (14). Cascade blue conjugations were performed in our laboratory using standard protocols. Stained cells were immediately analyzed on a modified FACSVantage SE/DiVa (BD Biosciences) and data were evaluated by FlowJo software (Tree Star, San Carlos, CA).
Statistical analyses
Statistical analyses were performed using Mann-Whitney U tests with STATVIEW 5.0.1 software (SAS Institute, Cary, NC).
| Results |
|---|
|
|
|---|
Recently, we established an ex vivo model whereby we expose LC within epithelial tissue explants to HIV, and then allow emigration of LC from tissue (9). In this study, to model interaction of LC with CD4+ T cells in vivo, we cocultured emigrated HIV-infected LC with autologous naive or memory peripheral blood CD4+ T cells. Before coculture with T cells, HIV infection levels in LC were determined by flow cytometry; infection levels varied among different skin donors (range, 0.94 to 15.6%; mean, 5.78%), consistent with our past results (9, 11). We previously have shown that emigrated LC exhibited a mature DC phenotype, including high expression of the costimulatory molecules CD40, CD80, CD86, and MHC class II (9), which is a phenotype known to facilitate clustering of DC with T cells (15).
HIV-infected mature LC transferred infection to cocultured CD4+ T cells as determined by HIV p24 positivity in gated T cell populations. Gating was performed so that background HIV p24 staining in cultures containing only T cells and in those cocultures containing uninfected LC and T cells were <0.07%. We previously confirmed a 1:1 relationship between the number of p24+ cells and copies of gag DNA (14), thus validating our multicolor flow cytometric analyses as an appropriate means to detect single HIV+ cells. HIV p24+ CD4+ T cells were detected in both naive and memory CD4+ T cell populations, however, CD4+ memory T cells were more susceptible to infection (Fig. 1). Addition of SEB increased proliferation of CD4+ T cells, however, SEB did not increase the overall percentages of p24+ CD4+ T cells in cocultures. In other words, the overall percentage of infected T cells did not increase with the addition of SEB because SEB induced a significant increase in the number of uninfected T cells. There was no relationship between infection levels in LC and those in CD4+ T cells (data not shown). This result is not surprising because in LC-T cell cocultures, HIV infection levels in T cells are more likely to be related to T cell activation by LC rather than to HIV infection levels in LC (5). In additional experiments described below, only CD4+ memory T cells were cocultured with LC.
|
DC (e.g., LC) readily form clusters when cocultured with T cells (12, 16). Such clusters are composed of one DC surrounded by numerous T cells. During staining procedures, these clusters are either disrupted or excluded by the flow cytometry machine. Thus, only conjugates of single DC with single T cells can be identified by expression of both DC and T cell markers when examined by flow cytometry. We used Abs directed against CD1a, a marker for LC, and CD3, pan-T cell marker, to identify conjugates. First, we gated on either proliferating or nonproliferating CD4+ memory T cells (i.e., CFSE diluted vs CFSE undiluted) and examined these two populations for evidence of LC-T cell conjugates. Populations of proliferating CD4+ T cells preferentially contained CD1a+CD3+ conjugates, whereas nondividing CD4+ T cells rarely contained CD1a+CD3+ conjugates (Fig. 2A). We confirmed those conjugates were larger and more granular (higher forward light scatter and higher side light scatter) as expected (data not shown). Most proliferating CD4+ T cells cultured without SEB were located in LC-T cell clusters (Fig. 2B). This general pattern occurred whether T cells were cocultured with HIV-infected or uninfected LC, or either in the presence or the absence of SEB (Fig. 2B). Of note, SEB decreased the overall percentage of conjugates, suggesting either increased number of proliferating CD4+ T cells per one cluster or increased proliferating CD4+ T cells located outside the clusters.
|
Next, we gated on either p24+ or p24- memory T cell populations and examined each group for evidence of LC-T cell conjugates. The HIV-infected p24+ CD4+ T cell population preferentially contained CD1a+CD3+ conjugates (Fig. 3A). In fact, CD1a+CD3+ conjugates were rarely observed in p24- cell populations. This general pattern occurred either in the presence or the absence of SEB (Fig. 3B). This suggested that T cells became infected through cluster formation with infected LC, rather than getting infected by free virus produced by single HIV-infected LC or T cells.
|
The relationship between HIV infection and CD4+ T cell proliferation was examined in more detail by examining proliferation, i.e., CFSE dilution, either in CD4+ memory T cells cocultured with HIV-infected LC or uninfected LC, or in gated populations of HIV-infected or uninfected CD4+ memory T cells. SEB induced more proliferation of CD4+ memory T cells whether they were cocultured with HIV infected or uninfected LC (Fig. 4A). The percentage of proliferating cells tended to be smaller and the division index, the average number of divisions that a cell has undergone, was significantly smaller when cocultured with HIV-infected LC (Table I). Next, we focused on gated populations of HIV-infected or uninfected CD4+ memory T cells. In cocultures grown in the absence of SEB, the p24+ CD4+ memory T cells were present in cell fractions that had divided 04 times and many showed >3 divisions (Fig. 4B). The percentage of proliferating cells and the division index were much higher compared with p24- CD4+ memory T cells (Table I). This suggests that the CD4+ T cells activated by HIV-infected LC avoid HIV-induced apoptosis, and continue to proliferate before starting to produce HIV virions (i.e., p24+). By contrast, in the presence of SEB, CD4+ T cells that expressed HIV p24 had either not divided or divided only once (Fig. 4B). The proliferation index, or the average number of divisions that a dividing cell has undergone, was smaller in infected (compared with uninfected) CD4+ T cells (Table I), suggesting that T cells activated by HIV-infected LC in the presence of SEB produce HIV virions rapidly and undergo apoptosis before significant proliferation occurs.
|
|
| Discussion |
|---|
|
|
|---|
In a previous report by our group (14), using a different experimental approach, we found that HIV preferentially infected HIV Ag-specific T cells. In that paper, naive and memory T cells were stimulated with SEB 3 days before HIV infection and then analyzed for p24 expression. We found that more p24 was expressed in naive T cells (or more correctly, in the cells that had been naive before they were exposed to SEB). In this current report, SEB was added at the time that LC and T cell cocultures were initiated. We also did not attempt to correlate HIV infection levels with Ag specificity using our LC-T cell system described in this study. In another paper by our group (17), we showed that memory T cells were more susceptible to SEB activation when compared with naive T cells. Thus, because memory T cells respond more readily to SEB activation, we believe this may be the reason why we saw higher p24 expression in memory T cells when compared with naive T cells in our current short-term culture experiments. Alternatively, memory T cells may have exhibited greater p24 expression because they interact with and respond to LC more readily than naive T cells (with or without SEB).
Our results suggest that most LC-mediated HIV infection of CD4+ T cells does not occur randomly or in the absence of some T cell selection. Recent reports have shown that HIV infection of DC induces expression of chemokines in these cells that differentially attract certain T cell subsets. HIV Tat or Nef protein expression within monocyte-derived DC increased production of IFN-inducible protein-10 and monokine induced by IFN-
(18, 19) or macrophage inflammatory protein-1
and -
, respectively (20, 21). These chemokines are ligands for either CXCR3 or CCR5, which are more highly expressed on memory CD4+ T cells as compared with naive T cells (22, 23). Thus, although we did not specifically study this in our system, it is possible that induction of specific chemokines within HIV-infected LC led to preferential chemoattraction and infection of memory CD4+ T cells (Fig. 1). Alternatively or additionally, because CCR5 is also important as a coreceptor for R5 HIV, differences in susceptibilities between naive and memory CD4+ T cells in our system could be attributed to higher expression levels of CCR5 in the latter cell population (data not shown).
Cellular activation is critical for replication of HIV (24). Not surprisingly, we preferentially detected conjugates of LC and autologous CD4+ T cells in populations of proliferating and HIV-infected CD4+ memory T cells, suggesting that T cells become activated and infected through cluster formation with infected LC rather than getting infected from free virus produced by single HIV-infected LC or T cells (Figs. 2 and 3). This is consistent with data from numerous groups who have identified the DC-T cell milieu as an explosive site for HIV replication. As emigrated LC exhibited a mature DC phenotype, it is not surprising that HIV-exposed LC cultured in the absence of exogenous Ag were able to induce cluster formation, activation, and infection in autologous T cells. CD4+ memory T cells cocultured with HIV-infected LC proliferated less compared with those cocultured with uninfected LC (Fig. 4A and Table I). The difference, however, was very small probably because of small percentages of HIV-infected LC in this system. This phenomenon was consistent with our previous report in which we showed that HIV-infected DC were poor stimulators of allogeneic CD4+ T cell proliferation and IL-2 production (10). Interestingly, in the presence of SEB, HIV-infected CD4+ T cells did not divide or divided only once (Fig. 4B). We hypothesize that virion production by CD4+ T cells is efficient and rapid in the presence of HIV-infected LC and SEB, inducing apoptosis of infected T cells before significant proliferation can occur. HIV-infected LC may have produced pro-apoptotic factors in the presence of SEB, because HIV-infected APCs have previously been reported to produce pro-apoptotic factors, including TNF-
(20, 21, 25), Fas ligand (25), and TNF-related apoptosis-inducing ligand (26, 27).
In summary, these results highlight that close interactions between DC, in this case epidermal LC, and T cells are important for optimal HIV replication within specific subsets of CD4+ T cells. Strategies designed to decrease conjugate formation between DC and T cells, and thus decrease T cell activation and proliferation, may be particularly effective in blocking the spread of HIV following sexual exposure to virus. One strategy may be to block chemotaxis of T cells toward HIV-infected DC using chemokine or chemokine receptor antagonists. A second strategy may involve blocking full activation of T cells by HIV-infected DC by addition of Abs that interfere with costimulatory molecule function.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Andrew Blauvelt, Dermatology Branch, Center for Cancer Research, National Cancer Institute, Building 10, Room 12N238, 10 Center Drive, Mail Stop Code 1908, Bethesda, MD 20892-1908. E-mail address: blauvelt{at}mail.nih.gov ![]()
3 Abbreviations used in this paper: LC, Langerhans cell; DC, dendritic cell; SEB, staphylococcal enterotoxin B. ![]()
Received for publication October 6, 2003. Accepted for publication December 4, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. N. Harman, M. Kraus, C. R. Bye, K. Byth, S. G. Turville, O. Tang, S. K. Mercier, N. Nasr, J. L. Stern, B. Slobedman, et al. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase Blood, July 2, 2009; 114(1): 85 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. van Montfort, A. A. M. Thomas, G. Pollakis, and W. A. Paxton Dendritic Cells Preferentially Transfer CXCR4-Using Human Immunodeficiency Virus Type 1 Variants to CD4+ T Lymphocytes in trans J. Virol., August 15, 2008; 82(16): 7886 - 7896. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawamura, Y. Koyanagi, Y. Nakamura, Y. Ogawa, A. Yamashita, T. Iwamoto, M. Ito, A. Blauvelt, and S. Shimada Significant Virus Replication in Langerhans Cells following Application of HIV to Abraded Skin: Relevance to Occupational Transmission of HIV J. Immunol., March 1, 2008; 180(5): 3297 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Fahrbach, S. M. Barry, S. Ayehunie, S. Lamore, M. Klausner, and T. J. Hope Activated CD34-Derived Langerhans Cells Mediate Transinfection with Human Immunodeficiency Virus J. Virol., July 1, 2007; 81(13): 6858 - 6868. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. U. Cameron, A. J. Handley, D. C. Baylis, A. E. Solomon, N. Bernard, D. F. J. Purcell, and S. R. Lewin Preferential Infection of Dendritic Cells during Human Immunodeficiency Virus Type 1 Infection of Blood Leukocytes J. Virol., March 1, 2007; 81(5): 2297 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bloch, F. J. Quintana, D. Gerber, T. Cohen, I. R. Cohen, and Y. Shai T-Cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif FASEB J, February 1, 2007; 21(2): 393 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Granelli-Piperno, I. Shimeliovich, M. Pack, C. Trumpfheller, and R. M. Steinman HIV-1 Selectively Infects a Subset of Nonmaturing BDCA1-Positive Dendritic Cells in Human Blood J. Immunol., January 15, 2006; 176(2): 991 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P Galvani The role of mutation accumulation in HIV progression Proc R Soc B, September 7, 2005; 272(1574): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Smed-Sorensen, K. Lore, J. Vasudevan, M. K. Louder, J. Andersson, J. R. Mascola, A.-L. Spetz, and R. A. Koup Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells J. Virol., July 15, 2005; 79(14): 8861 - 8869. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lore, A. Smed-Sorensen, J. Vasudevan, J. R. Mascola, and R. A. Koup Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells J. Exp. Med., June 20, 2005; 201(12): 2023 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Walker, H. Adle-Biassette, P. Madelenat, D. Henin, and T. Lehy Increased Apoptosis in Cervical Intraepithelial Neoplasia Associated with HIV Infection: Implication of Oncogenic Human Papillomavirus, Caspases, and Langerhans Cells Clin. Cancer Res., April 1, 2005; 11(7): 2451 - 2458. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |